TY - JOUR
T1 - Using a harmonic scalpel ''drilling and clamping'' method to implement zero ischemic robotic-Assisted partial nephrectomy
T2 - An observation case report study
AU - Hou, Chen Pang
AU - Lin, Yu Hsiang
AU - Hsu, Yu Chao
AU - Chen, Chien Lun
AU - Chang, Phei Lang
AU - Tsui, Ke Hung
N1 - Publisher Copyright:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Robot-Assisted partial nephrectomy (RAPN) has gradually become a popular minimally invasive nephron-sparing surgical option for small renal tumors. Ischemic injury should be minimized because it impacts renal function outcomes following partial nephrectomy. Herein, the authors detail the technique and present initial perioperative outcomes of our novel harmonic scalpel ''drilling and clamping'' method to implement zero-ischemic RAPN. The authors prospectively collected baseline and perioperative data of patients who underwent zero ischemic RAPN performed byour harmonic scalpel ''drilling and clamping''method.From April 2012 to December 2014, a total of 19 consecutive zero ischemic RAPN procedures were performed by a single surgeon. For 18 of the 19 patients, RAPN using our harmonic scalpel ''Drilling and Clamping'' method was successfully completed without the need for hilar clamping. Themediantumor sizewas 3.4 cm(range: 1.8-6.2); operative timewas3.2 hours (range: 1.9-4.5); blood loss was 100mL (range: 30-950); and postoperative hospital stay was 4 days (3-26). One patient required intraoperative blood transfusion. Two patients had intra or postoperative complications: 1 was converted to traditional laparotomy because of massive bleeding, whereas another had postoperative stress ulcer. Pathology confirmed renal cell carcinoma in 13 patients (63.2%), angiomyolipoma in 6 patients: (31.5%), and oncocytoma in 1 patient (5.3%). Mean pre-and postoperative serum creatinine (0.82mg/dL and 0.85mg/dL, respectively), estimated glomerular filtration rate (84.12 and 82.18, respectively), and hemoglobin (13.27 g/dL and 12.71 g/dL, respectively) were comparable. The authors present a novel zero-ischemic technique for RAPN. They believe that this technique is feasible and reproducible.
AB - Robot-Assisted partial nephrectomy (RAPN) has gradually become a popular minimally invasive nephron-sparing surgical option for small renal tumors. Ischemic injury should be minimized because it impacts renal function outcomes following partial nephrectomy. Herein, the authors detail the technique and present initial perioperative outcomes of our novel harmonic scalpel ''drilling and clamping'' method to implement zero-ischemic RAPN. The authors prospectively collected baseline and perioperative data of patients who underwent zero ischemic RAPN performed byour harmonic scalpel ''drilling and clamping''method.From April 2012 to December 2014, a total of 19 consecutive zero ischemic RAPN procedures were performed by a single surgeon. For 18 of the 19 patients, RAPN using our harmonic scalpel ''Drilling and Clamping'' method was successfully completed without the need for hilar clamping. Themediantumor sizewas 3.4 cm(range: 1.8-6.2); operative timewas3.2 hours (range: 1.9-4.5); blood loss was 100mL (range: 30-950); and postoperative hospital stay was 4 days (3-26). One patient required intraoperative blood transfusion. Two patients had intra or postoperative complications: 1 was converted to traditional laparotomy because of massive bleeding, whereas another had postoperative stress ulcer. Pathology confirmed renal cell carcinoma in 13 patients (63.2%), angiomyolipoma in 6 patients: (31.5%), and oncocytoma in 1 patient (5.3%). Mean pre-and postoperative serum creatinine (0.82mg/dL and 0.85mg/dL, respectively), estimated glomerular filtration rate (84.12 and 82.18, respectively), and hemoglobin (13.27 g/dL and 12.71 g/dL, respectively) were comparable. The authors present a novel zero-ischemic technique for RAPN. They believe that this technique is feasible and reproducible.
UR - http://www.scopus.com/inward/record.url?scp=84973459580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84973459580&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000002349
DO - 10.1097/MD.0000000000002349
M3 - Article
C2 - 26817867
AN - SCOPUS:84973459580
SN - 0025-7974
VL - 95
JO - Medicine (United States)
JF - Medicine (United States)
IS - 3
M1 - e2349
ER -